Biosenta Inc. announced earnings results for the third quarter ended June 30, 2021. For the third quarter, the company announced sales was CAD 644. Operating loss was CAD 884,246 compared to CAD 114,578 a year ago. Net loss was CAD 888,158 compared to CAD 112,951 a year ago. For the nine months, sales was CAD 150,761. Operating loss was CAD 1.701 million compared to CAD 459,807 a year ago. Net loss was CAD 1.711 million compared to CAD 558,393 a year ago.